ANTIKÖRPER UND POLYPEPTIDE, GERICHTET GEGEN CD127

European patent · EP3551664 · In force

Register entry

Publication number
EP3551664
Application number
EP17835592
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Dec 7, 2017
Published
Oct 16, 2019
Granted
Feb 17, 2021
Protection ends at the latest
Dec 6, 2037
Next annual fee due
Dec 31, 2026
IPC classes
C07K 16/28 (2006.01)
A61P 37/00 (2006.01)
Priority
EP 16306655 09.12.2016
PCT application
PCT/EP2017/081911 07.12.2017
PCT publication
WO2018/104483 14.06.2018
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 1, 2026

    Change

    Published in Swissreg on 01.01.2026

  2. Jan 1, 2025

    Change

    Published in Swissreg on 01.01.2025

  3. Jan 1, 2024

    Change

    Published in Swissreg on 01.01.2024

  4. Jan 1, 2023

    Change

    Published in Swissreg on 01.01.2023

  5. Dec 29, 2021

    Change

    Published in Swissreg on 29.12.2021

  6. Feb 17, 2021

    Granted

    Published in Swissreg on 17.02.2021

Parties

Holder

OSE Immunotherapeutics

22 Boulevard Benoni Goullin, 44200 Nantes, FR

Inventor

VANHOVE, Bernard

44400 Reze, FR

POIRIER, Nicolas

44119 Treillieres, FR

THEPENIER, Virginie

44680 Sainte Pazanne, FR

MARY, Caroline

44680 Sainte-Pazanne, FR

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.